Psoriatic Arthritis
📧 Sign up to get email alerts when something new happens for Psoriatic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis [Phase 2]
Phase 2 study evaluating guselkumab and golimumab combination therapy in active psoriatic arthritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-06Clinical Trial Update: A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis [Phase 3]
Phase 3 trial update evaluating long-term safety, tolerability, and efficacy of bimekizumab in active psoriatic arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2026-07-06Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis [Phase 3]
Phase 3 trial update for bimekizumab in adults with active psoriatic arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2026-06-29Clinical Trial Results: Diet Interventions in Psoriatic Arthritis [NA]
Completed clinical trial evaluating diet interventions in psoriatic arthritis; results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-22Clinical Trial Results: Multicentre ObservatioNal Initiative in Treat to Target Outcomes in Psoriatic Arthritis
Completed multicenter observational study in psoriatic arthritis assessing treat-to-target outcomes; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis [Phase 3]
A Phase 3 study evaluating the efficacy and safety of JNJ-77242113 (Icotrokinra) in biologic-naïve participants with active psoriatic arthri…
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis [Phase 3]
Phase 3 trial evaluating efficacy and safety of bimekizumab in adults with active psoriatic arthritis.
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Long-term Extension Study of Ustekinumab in Pediatric Participants [Phase 3]
Long-term extension study of ustekinumab in pediatric participants (Phase 3) for Crohn disease, ulcerative colitis, and related psoriatic ar…
-
CLINICAL_TRIALS trial_result · 2026-04-29Clinical Trial Update: Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug [Phase 3]
Phase 3 clinical trial evaluating sonelokimab in biologic DMARD–naive patients with active psoriatic arthritis is currently active but not r…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis [Phase 3]
A Phase 3 trial update evaluating the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in people with psoriatic arth…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: A Randomized, Double-blind Clinical Trial on the Efficacy of a Dietary Formulation Containing Medium-chain Triglycerides (MCT) and Fiber in Patients With Psoriatic Arthritis [NA]
This entry reports a completed randomized, double-blind trial evaluating a dietary formulation containing medium-chain triglycerides and fib…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis [Phase 2]
Phase 2 study evaluating the combination of guselkumab and golimumab for active psoriatic arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Long-term Extension Study of Ustekinumab in Pediatric Participants [Phase 3]
Long-term extension Phase 3 trial of ustekinumab in pediatric patients is being conducted for Crohn's disease and ulcerative colitis, with a…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis [Phase 3]
A Phase 3 study is assessing long-term safety, tolerability, and efficacy of bimekizumab in active psoriatic arthritis; the trial is current…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis [Phase 1]
A Phase 1 trial evaluating Allocetra via intra-articular injection for psoriatic arthritis has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease [Phase 4]
A Phase 4 clinical trial is evaluating the combination of deucravacitinib with a TNF inhibitor for difficult-to-control psoriatic disease in…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Sub-cutaneous Infliximab in Inflammatory Rheumatic Disease
Clinical trial update indicating a completed study of sub-cutaneous infliximab for inflammatory rheumatic diseases, including rheumatoid art…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Role of Intermittent Fasting in Psoriasis and Psoriatic Arthritis [NA]
A clinical trial investigating intermittent fasting for psoriasis and psoriatic arthritis has completed; no results are provided in the avai…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis [Phase 4]
This Phase 4 clinical trial registry entry describes evaluating upadacitinib's impact on spondyloarthritis outcomes in patients with active …
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.
Clinical trial update evaluating injection site pain and adherence when switching from a low to high concentration AVT-02 (adalimumab) acros…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2) [Phase 3]
This Phase 3 INSPIRE 2 trial compares tildrakizumab with placebo in anti-TNF-naïve adults with active psoriatic arthritis, reporting on effi…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis [Phase 3]
Phase 3 trial update evaluating long-term safety and efficacy of tildrakizumab in psoriatic arthritis; the study is ongoing but not currentl…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Use of Telemedicine to Address 'Off Target' Symptoms in Psoriatic Arthritis (PsA) [NA]
This entry reports the completed status of a University of Pennsylvania–sponsored clinical trial evaluating telemedicine to address off-targ…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
A non-US clinical trial is currently recruiting to evaluate treatment persistence with risankizumab in adults with psoriatic arthritis.
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System [NA]
Post-market clinical follow-up study of the A.L.P.S. Proximal Humerus Plating System by Zimmer Biomet is currently ACTIVE_NOT_RECRUITING, ex…